Esculin was found to significantly alleviate the symptoms of colitis and suppress the expression of inflammatory factors including inducible nitric oxide synthase (iNOS), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) in vivo and in vitro. Here, IL1B is linked to colitis.